SeraCare, one of the top 10 companies in the US plasma collectionindustry, is to purchase Western States Group, subject to approval by the respective boards of directors.
WSG, which posted sales of approximat ely $10 million in 1996, is a worldwide marketing organization for therapeutic-based blood products, diagnostic test kits and bulk materials. The group's founder, Michael Crowley, said he would be "pleased to be part of an aggressively growing company such as SeraCare."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze